Stock Market

A Biogen facility in Cambridge, Massachusetts.
Brian Snyder | Reuters

Check out the companies making headlines in midday trading.

Apple — Apple shares fell 3.4% on Wednesday following a report that the company is ditching plans to boost new iPhone production. Instead of aiming to increase output by 6 million units in the second half of the year as it had planned, it will shoot for 90 million units, unchanged from the prior year, according to Bloomberg.

Biogen — Shares of the biopharmaceutical company soared 37% following upbeat results from its experimental Alzheimer’s drug study and a slew of upgrades from analysts. Biogen and its Japanese partner Eisai said the drug reduced cognitive decline by 27% and slowed the progression of the disease.

Broadridge — Spruce Point Capital Management issued report containing a strong sell opinion, saying it sees as much as 75% downside risk.

Illumina — The biotech company saw shares climb 8% after Evercore ISI upgraded the stock to outperform from in line, saying it’s bullish on Illumina’s new products as it comes out of a “multi year underperformance” period.

Netflix — Shares of the streaming giant jumped more than 6% after Atlantic Equities upgraded the stock to overweight, saying Netflix’s lower-cost, ad-supported subscriber tier, which it plans to launch in coming months, could boost its share price by 26%.

Thor Industries — Shares jumped 3.4% after the recreational vehicle maker topped profit and revenue expectations in its most recent quarter. Thor said its motorized RV segment saw a 24.5% gain from the prior year.

Ocugen — The drugmaker’s shares soared by about 8% after it came to a licensing agreement with Washington University in St. Louis to develop, commercialize and manufacture its intranasal Covid-19 vaccine.

Canopy Growth — Shares of the cannabis company were up 2.6% on plans to pull back from its retail operations in Canada. Ontario-based Canopy said earlier this year it was extending its timeline for profitability.

DocuSign — Shares of the electronic signature service rose about 5.4% after announcing Wednesday it would shed about 9% of its workforce as part of a restructuring. The company expects to incur costs of as much as $40 million as part of the plan.

Paychex — Shares of the payroll company gained more than 2% after earnings and revenue before the bell beat expectations. It also raised its earnings outlook for the year.

 — CNBC’s Alex Harring, Samantha Subin, Michelle Fox and Sarah Min contributed reporting.

Articles You May Like

Colorado bond authority eyes purchase of hotel that inspired The Shining
Balancing Act: Lander says $12B hike in NYC’s debt limit is reasonable
US accuses Apple of building smartphone market monopoly in antitrust case
Top Wall Street analysts like these dividend stocks for portfolio income
Benefits from not-yet-begun Manhattan congestion toll delayed by lawsuits